| Q98513784 | A dynamic COVID-19 immune signature includes associations with poor prognosis |
| Q34063158 | A variant of SCID with specific immune responses and predominance of gamma delta T cells |
| Q36988166 | Age-associated alterations in γδ T-cells are present predominantly in individuals infected with Cytomegalovirus |
| Q34413233 | Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors |
| Q38798990 | Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells |
| Q39160154 | Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma. |
| Q36074884 | Antiviral reactivities of gammadelta T cells |
| Q54709650 | Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. |
| Q38151057 | At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias |
| Q80534935 | CD3 bright lymphocyte population reveal gammadelta T cells |
| Q92308099 | CD8+ γδ T Cells Are More Frequent in CMV Seropositive Bone Marrow Grafts and Display Phenotype of an Adaptive Immune Response |
| Q40103015 | Comparative Peripheral Blood T Cells Analysis Between Adult Deceased Donor Liver Transplantation (DDLT) and Living Donor Liver Transplantation (LDLT). |
| Q37723095 | Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation |
| Q27322847 | Control of murine cytomegalovirus infection by γδ T cells |
| Q33562109 | Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age. |
| Q40332777 | Cytomegalovirus infection alters phenotypes of different γδ T-cell subsets in renal transplant recipients with long-term stable graft function. |
| Q73179716 | Cytomegalovirus infection associated with clonal proliferation of T-cell large granular lymphocytes: causal or casual? |
| Q33562231 | Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation |
| Q34427661 | Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions |
| Q47403044 | Cytomegalovirus-specific IFN-γ production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy |
| Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
| Q59798150 | Deciphering the Contribution of γδ T Cells to Outcomes in Transplantation |
| Q26863724 | Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation |
| Q64103902 | Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B |
| Q41306288 | Donor Vδ1+ γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL. |
| Q93109123 | Emerging role of γδ T cells in vaccine-mediated protection from infectious diseases |
| Q55008660 | Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility. |
| Q57039659 | Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of γδ T cells |
| Q92735606 | Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders |
| Q21131157 | Human Peripheral CD4(+) Vδ1(+) γδT Cells Can Develop into αβT Cells |
| Q35233773 | Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients |
| Q33795023 | Human cytomegalovirus elicits fetal gammadelta T cell responses in utero |
| Q90062898 | Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease |
| Q34426299 | Immunity to cytomegalovirus in early life. |
| Q37050965 | Immunobiology of human cytomegalovirus: from bench to bedside. |
| Q45364081 | Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy |
| Q36835155 | Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection |
| Q42637895 | Lower incidence of chronic allograft nephropathy at 1 year post-transplantation in patients treated with mycophenolate mofetil |
| Q39051240 | Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy. |
| Q55237064 | Molecular Determinants of Target Cell Recognition by Human γδ T Cells. |
| Q34358755 | Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation |
| Q27319958 | Natural Killer Cell Sensing of Infected Cells Compensates for MyD88 Deficiency but Not IFN-I Activity in Resistance to Mouse Cytomegalovirus |
| Q36348587 | Peripheral blood T-cell signatures from high-resolution immune phenotyping of γδ and αβ T-cells in younger and older subjects in the Berlin Aging Study II |
| Q38152686 | Quantitative peripheral blood perturbations of γδ T cells in human disease and their clinical implications |
| Q52313512 | Recasting Human Vδ1 Lymphocytes in an Adaptive Role. |
| Q35154002 | Regulation and function of IL-17A- and IL-22-producing γδ T cells. |
| Q40392303 | Severe Symptomatic Primary Human Cytomegalovirus Infection despite Effective Innate and Adaptive Immune Responses |
| Q36403003 | Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells |
| Q27010451 | Six-of-the-best: unique contributions of γδ T cells to immunology |
| Q40147291 | Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction |
| Q40428945 | T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes. |
| Q41118007 | TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance |
| Q59806979 | Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells |
| Q84736367 | Variability of CD3 membrane expression and T cell activation capacity |
| Q84028052 | [Immunological monitoring strategies for cytomegalovirus infection. Immune-based therapies] |
| Q37632938 | γδ T Cell-Mediated Immunity to Cytomegalovirus Infection. |
| Q35573003 | γδ T cells confer protection against murine cytomegalovirus (MCMV). |
| Q100560002 | γδ T cells in tissue physiology and surveillance |
| Q35634919 | γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes |
| Q85818563 | γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia |